AI now explains your products.
Who in your company sees what it says?
Patients and pharmacists ask AI assistants about dosing, age limits and interactions – often without ever visiting your website. I measure verbatim what these systems state about your products, verify every claim against your approved information, and trace each error to the team that can fix it.
Widely used, unstable and rarely cited.
When AI assistants answer clinical or consumer health questions, they blend official regulatory texts with third-party forums, outdated PDFs and foreign market approvals.
-
1 in 3
US adults use AI chatbots for health information – matching the share who use social media.
Source: KFF, March 2026 (US data; comparable Swiss figures not yet published).
-
5–13 %
of chatbot answers to 222 patient questions about medicines were rated unsafe, depending on the model.
Source: Draelos et al., arXiv preprint, 2025 (888 answers, not peer-reviewed).
-
54 %
of an AI search chatbot’s answers to common questions about the 50 most prescribed drugs matched scientific consensus.
Source: Andrikyan et al., BMJ Quality & Safety, 2025 (Bing Copilot, 500 answers).
Answers with a safety-relevant deviation from the approved information, each one checked by hand before it is reported.
Verifiable product statements that match the approved information, against those that contradict it.
Statements the approved sources neither confirm nor contradict, such as a guessed standard dose.
“Adults can take up to 30 ml of Musterflu per day.”
“Adults: no more than 20 ml per day.”
Likely source: the answer cites a foreign pharmacy page for a version with a different strength. The Swiss dosing sits only in a PDF and is not cited.
-
01 · Publish Swiss strength and maximum dose as HTML Web & Regulatory
Put the approved dosing on the product page, so search-augmented AI can read and cite it.
-
02 · Mark the country version clearly Regulatory
State country and strength wherever the product is described, so foreign versions are not mixed in.
-
03 · Align product naming across DE / FR / IT Digital Governance
Consistent names in all national languages make it harder for models to blend in foreign data.
Set up once. Measure on a fixed cycle.
I test 12 realistic questions per product, plus up to two of yours, across ChatGPT, Claude, Gemini and Perplexity, five times each through the APIs and the safety questions also by hand in the apps, and verify every statement against facts your team has confirmed.
Establish the verified baseline
- 1Add brand & marketsDefine products, languages and target geographies.
- 2Read in official sourcesIngest approved web pages, IFUs and package leaflets.
- 3Confirm reference factsA qualified person on your side confirms each reference statement.
- 4Select key messagesDefine up to 10 core safety or positioning facts to track.
- 5Fix the question set12 everyday patient or pharmacist queries per product, plus up to two of your own.
- 6Run baseline measurementAutomated multi-run capture across models with human sample review.
Track remediation impact
- 7Review findings & sampleHuman verification of flagged safety risks and contradictions.
- 8Assign remediation measuresPrioritised action list per topic, mapped to Regulatory, Medical or Web owners.
- 9Verify effect in next runRe-run the exact same prompts (logged by model version and date) to show whether the answers changed after your fixes.
Seravel is my proprietary measurement instrument, currently in beta. For the pilot phase I am partnering with OTC and medtech organisations. Read about Seravel and the method →
Two ways in. One clear bridge.
Product pages, leaflets, directory entries and press releases are maintained by different teams and external agencies. When nobody owns the whole architecture, outdated versions stay online – and AI models surface them. Where cross-functional ownership is the real gap, I step in on the client side for a fixed term.
AI Answer Audit
For Medical, Regulatory and Brand leads who need immediate clarity on what AI assistants tell patients and professionals about their products.
Fixed-Term Digital Leadership
For executives facing a major platform decision, multiple agencies without unified delivery steering, or a vacant digital leadership role.
What executives ask first.
Clear boundaries on governance, compliance and how client-side advisory differs from agency work.
Why does this matter if the AI is not ours?
Because patients and healthcare professionals act on the answer directly in the chat, often without visiting your website. If an assistant states an outdated dose or omits a warning, the person asking may never see your approved information. You cannot control the model, but you can audit what it states, trace which sources it relies on, and remove outdated copies still online.
Is this pharmacovigilance or medical information?
No. The audit is not a pharmacovigilance or medical-information service, and it gives no medical or legal advice. It measures verbatim what AI assistants say and where errors likely originate. Your existing processes for drug safety, medical enquiries and regulatory approvals remain strictly in charge.
Can you make the AI answer correctly?
No external party controls model weights or provider algorithms. What you directly influence is your own digital evidence: structured HTML product pages, current leaflets, and clean directory data. The audit shows where to act, and the re-measurement every 28 days shows whether answers have changed.
How is this different from a consultancy or an agency?
I am not an implementation agency. My role is strictly client-side: measuring, framing decisions, evaluating vendors, setting acceptance criteria and steering delivery. I take no vendor commissions and no agency margins, which ensures recommendations hold even when they cost a supplier the contract.
Start with one product – or one conversation.
For the free Seravel Snapshot, send me your company, the product name, desired languages and a contact. You receive one page within 3 working days, every finding checked by a person. If your priority is an upcoming platform decision or a leadership gap, book a confidential call instead.
Please do not send confidential or personal data before we agree a secure channel and scope.
Or write directly: kevin.lancashire@lancashire-digital.ch
Not ready to name a product? Check AI answers yourself

